Search

C3 to raise $10m through underwritten share purchase plan

Perth-based burns treatment developer Clinical Cell Culture Ltd, or C3, will raise $10 million through a share purchase plan to existing shareholders for further commercialisation of the company's ReCell product.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNIQ sponsored byECU School of Business and Law

Students

6th-Australian Institute of Management WA20,000
7th-Murdoch University16,584
8th-South Regional TAFE10,549
9th-Central Regional TAFE10,000
10th-The University of Notre Dame Australia6,708
47 tertiary education & training providers ranked by total number of students in WA

Number of Employees

BNiQ Disclaimer